4//SEC Filing
Bhadauria Pradeep 4
Accession 0001723128-19-000129
CIK 0001723128other
Filed
Nov 13, 7:00 PM ET
Accepted
Nov 14, 5:26 PM ET
Size
7.5 KB
Accession
0001723128-19-000129
Insider Transaction Report
Form 4
Bhadauria Pradeep
SVP, Chief Scientific Officer
Transactions
- Disposition to Issuer
Stock Option
2019-11-13−153,846→ 0 totalExercise: $13.28Exp: 2029-04-15→ Class A Common Stock (153,846 underlying) - Award
Stock Option
2019-11-13+153,846→ 153,846 totalExercise: $2.75Exp: 2029-04-15→ Class A Common Stock (153,846 underlying)
Footnotes (1)
- [F1]The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on April 15, 2019, and will vest in four equal annual installments beginning on April 15, 2020.
Documents
Issuer
Amneal Pharmaceuticals, Inc.
CIK 0001723128
Entity typeother
Related Parties
1- filerCIK 0001774812
Filing Metadata
- Form type
- 4
- Filed
- Nov 13, 7:00 PM ET
- Accepted
- Nov 14, 5:26 PM ET
- Size
- 7.5 KB